Publications by authors named "Chunqin Deng"

Claim this Profile
B
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Sandeep Sahay, Harold Palevsky, Karim El-Kersh, Ricardo Restrepo-Jaramillo, Abubakr A Bajwa, Chunqin Deng

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Steven D Nathan, Eric Shen, Chunqin Deng

Chest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
Steven D Nathan, Shilpa Johri, Joanna M Joly, Christopher S King, Amresh Raina, Chunqin Deng

Thorax· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
Jason Weatherald, Steven D Nathan, Karim El-Kersh, Rahul G Argula, Hilary M DuBrock, Chunqin Deng

BMJ Open Respir Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
Ekkehard Grünig, Franck Rahaghi, Jean Elwing, Carmine Dario Vizza, Joanna Pepke-Zaba, Chunqin Deng

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial.
Steven D Nathan, Boris Medarov, Lawrence Ho, John Kingrey, Taekwon Hong, Chunqin Deng

Ann Am Thorac Soc· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Aaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Peter Engel, Abubakr Bajwa, Chunqin Deng

Eur Respir J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Steven D Nathan, Chunqin Deng, Christopher S King, Hilary M DuBrock, Jean Elwing

Chest· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
Raymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, Carmine Dario Vizza, Meredith Broderick, Chunqin Deng

J Heart Lung Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Leslie A Spikes, Abubakr A Bajwa, Charles D Burger, Sapna V Desai, Michael S Eggert, Chunqin Deng

Pulm Circ· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.
Steven D Nathan, Victor F Tapson, Jean Elwing, Franz Rischard, Jinesh Mehta, Chunqin Deng

Am J Respir Crit Care Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.
Rajeev Saggar, Paresh C Giri, Chunqin Deng, Dana Johnson, Mary K McCloy

Pulm Circ· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Aaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter Engel, Chunqin Deng

N Engl J Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension.
Sylvia Nikkho, Peter Fernandes, R James White, Chunqin Cq Deng, Harrison W Farber

Pulm Circ· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Russell L Chin, Chunqin Deng, Vera Bril, Hans-Peter Hartung, Ingemar S J Merkies

Muscle Nerve· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design.
Chunqin Deng, Kim Hanna, Vera Bril, Marinos C Dalakas, Peter Donofrio

J Neurol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiologic correlations with clinical outcomes in CIDP.
Vera Bril, Marta Banach, Marinos C Dalakas, Chunqin Deng, Peter Donofrio

Muscle Nerve· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.
Peter D Donofrio, Vera Bril, Marinos C Dalakas, Chunqin Deng, Kim Hanna

Arch Neurol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
Ingemar S J Merkies, Richard A C Hughes, Peter Donofrio, Vera Bril, Marinos C Dalakas, Chunqin Deng

J Peripher Nerv Syst· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Norman Latov, Chunqin Deng, Marinos C Dalakas, Vera Bril, Peter Donofrio

Arch Neurol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
David G Parr, Asger Dirksen, Eeva Piitulainen, Chunqin Deng, Marion Wencker

Respir Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
Vera Bril, Hans Katzberg, Peter Donofrio, Marta Banach, Marinos C Dalakas, Chunqin Deng

Muscle Nerve· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Richard A C Hughes, Peter Donofrio, Vera Bril, Marinos C Dalakas, Chunqin Deng

Lancet Neurol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.
David G Parr, Martin Sevenoaks, Chunqin Deng, Berend C Stoel, Robert A Stockley

Respir Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study.
David I Bernstein, Cheryl K Bernstein, Chunqin Deng, Karen J Murphy, I Leonard Bernstein

Ann Allergy Asthma Immunol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis